• Nuclear Engineering and Technology
• /
• v.4 no.3
• /
• pp.186-193
• /
• 1972

For efficient micro scale syntheses of Rose $Bengal-^{131}I$, $Hippuran-^{131}I$, and $H.S.A.-^{131}I$, the dependence of labelling yields on pH, on salt contents, and on the volume of buffer solution in the reaction mixtures as well as the reaction apparatus were studied. pH of 5.6 was optimum for preparation of both Rose $Bengal-_{131}I$ and Hippuran $-^{13}I$ but pH of 8.5 was optimum for preparation of $H.S.A.-^{131}I$. Salt in the reaction mixtures hindered drastically the formation of $Hippuran-^{131}I$ but it slightly increased the labelling yield of H.S.A.. The compactly closed reaction vessels were effective for preparations of both Rose $Bengal-^{131}I$and $Hippuran-^{131}I$ in small volume. Thereupon, the labelling procedures were modified to bring about higher labelling yields and better reproducibilities. By these newly established procedures, the labelling yields of Rose $Bengal-^{131}I$ and $Hippuran-^{131}I$ could be increased even with the home-produced sodium $iodide-^{131}I$ solution containing reducing agent.

• Nuclear Engineering and Technology
• /
• v.3 no.3
• /
• pp.141-147
• /
• 1971

In iodine-131 labelling of iodocompounds such as tetrachloro-P-tetraiodo R-fluorescein, sodium orthoiodohippurate and a non-iodocompound, human serum albumin (HSA), the labelling rates and yields are accurately compared with each other. The reaction systems conducted for each compounds were different conditions: sodium iodide-$^{131}$ I containing reducing agent, sodium iodide-$^{131}$ I free from reducing agent, and sodium iodide-$^{131}$ I free from reducing agent but containing considerable amount of iodide-$^{131}$ I etc. The labelling yields were generally poor; 10% in the case of using sodium iodide-$^{131}$ I containing redoing agent, and 50~60% in the case of using sodium iodide-$^{131}$ I free from reducing agent but containing considerable amount of iodide-$^{131}$ I. However, fair yields were obtained in the case of using sodium iodide-$^{131}$ I free from reducing agent and mostly in the form of iodide-$^{131}$ I. The reaction entities involved in these reactions are also briefly discussed.

• The Korean Journal of Nuclear Medicine
• /
• v.33 no.6
• /
• pp.493-501
• /
• 1999

Purpose: We conducted a comparative study to evaluate the diagnostic values of T1-201, Tc-99m MIBI and I-131 scans in the follow-up assessment after ablative I-131 therapy in differentiated thyroid cancer. Materials and Methods: The study population consisted of 20 patients who underwent surgical removal of thyroid cancer and ablative radioactive iodine therapy, and followed by one or mote times of I-131 retreatments (33 cases). In all patients, T1-201, Tc-99m MIBI, diagnostic and therapeutic I-131 scans were performed and the results were analyzed retrospectively. Also serum thyroglobulin levels were measured in all patients. The final diagnosis of recurrent or metastatic thyroid cancer was determined by clinical, biochemical, radiologic and/or biopsy findings. Results: Positive rates (PR) of Tc-99m MIBI, T1-201, diagnostic and therapeutic I-131 scans in detecting malignant thyroid tissue lesions were 70% (19/27), 54% (15/28), 35% (17/48) and 63% (30/48), respectively. The PR in the group of 20 cases (28 lesions) who underwent concomitant T1-201 and I-131 scans were in the order of therapeutic 131 scan 71%, T1-201 scan 54% and diagnostic I-131 scan 36%. There was no statistically significant difference between T1-201 and diagnostic I-131 scans (p>0.05). In the group of 20 cases (27 lesions) who underwent concomitant Tc-99m MIBI and I-131 scans, the PR were in the order of Tc-99m MIBI scan 70%, I-131 therapeutic scan 52% and I-131 diagnostic scan 33%. The PR of Tc-99m MIBI was significantly higher than that of diagnostic I-131 scan (p<0.05). Conclusion: Tc-99m MIBI scan is superior to diagnostic I-131 scan in detecting recurrent or metastatic thyroid cancer following ablation therapy in patients with differentiated thyroid cancer. T1-201 scan did not showed significantly higher positive rate than diagnostic I-131 scan. Instead of diagnostic I-131 scan before the I-131 retreatment, Tc-99m MIBI scan without discontinuing thyroid hormone replacement would be a prudent and effective approach in the management of these patients.

• Nuclear Medicine and Molecular Imaging
• /
• v.43 no.6
• /
• pp.582-587
• /
• 2009

A 59-year-old woman who was diagnosed with malignant pheochromocytoma underwent $^{18}F$-fluorodeoxyglucose positron emission tomography/computed tomography ($^{18}F$-FDG PET/CT). She had undergone left adrenalectomy for pheochromocytoma 4 years previously. Recent multiple metastatic pulmonary nodules were noted on the chest X-ray. After treatment with $^{131}I$-metaiodobenzylguanidine ($^{131}I$-MIBG) with 7.4 GBq, post-therapy $^{131}I$-MIBG scintigraphy depicted multiple distant metastases including lung, liver, abdominal para-aortic and mesenteric lymph nodes. $^{18}F$-FDG PET/CT also depicted multiple metastases in lung, liver, and abdominal para-aortic lymph nodes, but some lesions were not shown. In this case, $^{131}I$-MIBG scintigraphy found additional lesions in metastatic malignant pheochromocytoma.

• The Korean Journal of Nuclear Medicine
• /
• v.2 no.1
• /
• pp.43-48
• /
• 1968

A comparative study of $^{131}I$-hippuran renogram, $^{131}I$-hippuran excretion test and intravenous pyelogram were performed in 61 cases of gynecological cancer. The following were the results: 1. Among 40 cases of cervix cancer showing normal excretory urography 7 cases (17.5%) were found to have unilateral or bilateral delayed excretory pattern on $^{131}I$-hippuran renogram and on the contrary only 2 cases (5.7%) showed a mild caliectatic change on excretory urography among 35 cases of gynecological cancer showing normal pattern of $^{131}I$-hippuran renogram. 2. In the group showing unilateral or bilateral delayed excretory pattern on $^{131}I$-hippuran renogram there was a reduction of $^{131}I$-hippuran excretion in the first 20 minutes, but there was no significant difference of $^{131}I$-hippuran excretion in 60 minutes compared with that of normal renogram group. 3. In the group showing unilateral non-functioning pattern of $^{131}I$-hippuran renogram in one side and normal pattern in the other side there was found to be no difference in $^{131}I$-hippuran excretion amount compared with that of normal renogram group. 4. It was evident from these experimental study that $^{131}I$-hippuran renogram was considered as a good examination method for the evaluation of obstructive uropathy, and if one side kidney was intact it might compensate for the other diseased kidney so far as to renal excretory function. It was also shown that the more severe the cancerous spread in the pelvic wall the more changes on $^{131}I$-hippuran renogram.

• Korean Journal of Veterinary Research
• /
• v.7 no.2
• /
• pp.35-41
• /
• 1967

In these studies, the relationship of the thyroid function of normal and unilateral thyroidectomized rabbit, were st studied. $I^{131}$ uptake rate of the thyroid gland, the concentration of the $PBI^{131}$ and $I^{131}$ in the blood, erum $PBI^{131}$ conversion ratio, and the thyroidal $I^{131}$ release rate in ten rabbits were mesured following a single intramuscular injection of $10{\mu}ci$ of $I^{131}$. 1. The thyroidal $I^{131}$ uptake rate in the treated group were 5.06, 8.58, 6.46, and 6.54% in 12, 36, 60 and 85 hrs., respectively, after injection of $I^{(3)}$. The uptake rate were significantly differrenciate between the two groups. (P<0.05) 2. The $PBI^{(3)}$ conversion ratios were 9.87, 15.63, 41.01, 66.25 and 66.25% in 12, 36, 132, 180 hrs., respectively, after injection of $I^{131}$. No significant difference was observed between the groups. 3. The concentration of $PBI^{131}$ and $I^{131}$ in the blood were significant between the groups. 4. The excretion rate of $I^{131}$ in urine was not significant between two groups, but the excretion of $I^{131}$ in the treated group was higher than that of the control group. 5. The exrcetion rate of $I^{131}$ in feces in the treated group were significantly higher than the control group. (p<0.01)

• Nuclear Engineering and Technology
• /
• v.5 no.3
• /
• pp.234-239
• /
• 1973

A recently known method of paper chromatographical separation of o-iodobenzoic acid-$^{131}$ I and o-iodohippuric acid-$^{131}$ I was found to be in error. The solvent mixture proposed in the method for the efficient separation of the two compounds of similar structure not only be made nonhomogeneous but also brings about no separation. It was also confirmed that no o-iodohippuric acid is converted to o-iodobenzoic acid during the process for Hippuran -$^{131}$ I preparation by isotopic exchange. Upon it, an alternate method of chromato-graphical determination of radiochemical purity of Hippuran-$^{131}$ I is proposed in present paper.

• The Korean Journal of Nuclear Medicine
• /
• v.32 no.3
• /
• pp.290-297
• /
• 1998

Purpose : The aim of this study was to evaluate the feasibility of 3-[$^{131}I$]iodo-O-methyl-L-${\alpha}$-methyltyrosine ([$^{131}I$]OMIMT) as an agent for tumor image. Materials and Methods : After synthesis of 4-O-methyl-L-${\alpha}$-methyltyrosine (OMAMT), OMAMT was labeled with [$^{131}I$] using Iodogen method. In vitro cellular uptake study was performed using 9 L gliosarcoma cells at various time points upto 4 hr. The biodistribution (five rats implanted with the 9 L gliosar-coma cells per group) was evaluated at 30 min, 2 hr, 24 hr after iv injection of 3.7 MBq [$^{131}I$]OMIMT or L-3-[$^{131}I$]iodo-${\alpha}$-methyltyrosine [$^{131}I$]IMT). Gamma camera images were obtained at 30 min, 2 hr and 24 hr. Results: [$^{131}I$]OMIMT uptake was 3.3 times and 2.5 times higher than [$^{131}I$]IMT uptake at 30 min and 60 min, respectively and same after 2 hr in in vitro study using 9L gliosarcoma cells. Maximum accumulation in tumor occurred at 30 min for both [$^{131}I$]OMIMT and [$^{131}I$]IMT in tumor bearing rats. The tumor uptake of [$^{131}I$]OMIMT was significantly higher than that of [$^{131}I$]IMT at early time point studied ($3.74{\pm}0.48$ vs $0.38{\pm}0.17%$ ID/g at 30 min and $2.40{\pm}0.17$ vs $0.24{\pm}0.03%$ ID/g at 2 hr, respectively, p<0.01). However, the tumor uptake of both radiolabels were not significantly different at 24 hr ($0.04{\pm}0.01$ vs $0.05{\pm}0.01%$ ID/g). Tumor was visualized as early as at 30 min in gamma camera images. Conclusion: These data suggested that [$^{131}I$]OMIMT might be a useful tumor imaging agent and has more advantage for the tumor imaging compared to [$^{131}I$]IMT

• The Korean Journal of Nuclear Medicine
• /
• v.37 no.2
• /
• pp.120-127
• /
• 2003

Purpose: To evaluate diagnostic sensitivity of nuclear imaging in the detection of residual thyroid tissue and metastatic lesion, we have compared neck scintigrams with Tc-99m pertechnetate (Tc-99m scan) and high dose I-131 iodide (I-131 scan) in patients with differentiated thyroid cancer. Subjects and Methods: One hundred thirty-five thyroidectomized patients for differentiated thyroid cancer were enrolled in this study. Twenty-three had a previous history of radioiodine therapy. Planar and pin-hole images of anterior neck with Tc-99m were acquired at 20 minutes after injection, followed by I-131 scan three days after high-dose radioiodine therapy within 7 days interval. Patients were asked to discontinue thyroid hormone replacement more than 4 weeks. Results: All subjects were in hypothyroid state. Seventy out of 135 patients (51.9%) showed concordant findings between Tc-99m and I-131 scans. I-131 scan showed higher number of uptake foci in all of 65 patients showing discordant finding. Tc-99m scan showed no thyroid bed uptake in 34 patients, whereas 23 of them (67.6%) showed bed uptake in I-131 scan. Tc-99m scan did not show any uptake in thyroid bed in 11 of 112 patients without previous history of radioiodine therapy, but 9 of them showed bed uptake in I-131 scan. Tc-99m scan showed no bed uptake in all of the 23 patients with previous history of radioiodine therapy, in contrast 14 of them (60.9%) showed bed uptake in I-131 scan. Conclusion: These results suggest that Tc-99m scan has poor detectability for residual thyroid tissue or metastatic lesion in thyroidectomized differentiated thyroid cancer patients, compared to high dose I-131 therapy scan. Tc-99m scan could not detect any remnant tissue or metastatic lesion in patients with previous history of radioiodine treatment, especially.

• Korean Journal of Head & Neck Oncology
• /
• v.16 no.2
• /
• pp.206-211
• /
• 2000

Objectives: Any uptake of I-131 after total thyroidectomy means the remant thyroid tissue or distant metastasis of the thyroid cancer. However diffuse hepatic uptake of I-131 without abnormal uptake was showen in many cases on I-131 whole body scan. The aim of this study was to classify the liver uptake after I-131 scan and to evaluate the analysis of this finding. Materials and Methods: Between 1982 and 1998, 104 patients(l4 males, 90 females) with normal liver function underwent I-131 scan after total thyroidectomy. Prospectively we reviewed the films of the whole body scan and analysed the correlations between results of radioiodine uptake, pathologic diagnosis, prognostic factors, lymphatic metastasis, and thyroid function test. Result: Diffuse hepatic uptake was found in 44 of 104(42%) patients. 10 of 39(26%) patients on I-131 100mCi, and 34 of 63(54%) on I-131 150mCi showed hepatic uptake. 52 of 104(50%) patients was locally invasive thyroid cancer. The rate of the hepatic uptake was no significant differences with the thyroid hormone levels(T3, Free T4) and thyroglobulin between uptake group and non-uptake group. Conclusion: The rate of I-131 uptake was high in high-dose radioiodine treatment group. However, we can not find any correlation among the thyroid functions, the extent of metastasis or the extent of local invasion. We need further study to find out the causes of the hepatic uptake of I-131 after total thyroidectomy, besides liver metabolism of I-131 attached thyroid hormones.